Design, synthesis and antitumor evaluation of novel 1H-indole-2-carboxylic acid derivatives targeting 14-3-3? protein

被引:5
作者
Gao, Zhenxiong [1 ,2 ]
Fan, Tingting [2 ,3 ]
Chen, Linbo [2 ,3 ]
Yang, Mengchu [4 ]
Wong, Vincent Kam Wai [4 ]
Chen, Dawei [5 ,6 ]
Liu, Zijian [5 ,6 ]
Zhou, Yaoyao [2 ]
Wu, Weibin [5 ,6 ]
Qiu, Zixuan [2 ]
Zhang, Cunlong [5 ,6 ,10 ]
Li, Yuan [7 ]
Jiang, Yuyang [2 ,3 ,8 ,9 ]
机构
[1] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China
[2] Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Guangdong Prov Key Lab Chem Biol, Shenzhen 518055, Peoples R China
[3] Southern Univ Sci & Technol, Dept Chem, Shenzhen 518055, Peoples R China
[4] Macau Univ Sci & Technol, Dr Nehers Biophys Lab Innovat Drug Discovery, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[5] Shenzhen Kivita Innovat Drug Discovery Inst, Shenzhen 518057, Peoples R China
[6] Shenzhen Bay Biopharm Technol Co Ltd, Shenzhen 518057, Peoples R China
[7] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Sch Publ Hlth, Nanjing 211166, Peoples R China
[8] Tsinghua Univ, Sch Med, Dept Pharmacol & Pharmaceut Sci, Beijing 100084, Peoples R China
[9] Inst Biomed Hlth Technol & Engn, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China
[10] Shenzhen Bay Biopharm Technol Co Ltd, Shenzhen Kivita Innovat Drug Discovery Inst, Shenzhen 518057, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; 14-3-3? protein; Novel target; Drug design; Antitumor bioactivity; HEPATOCELLULAR-CARCINOMA; ACTIVATION; INHIBITORS; SORAFENIB; DISCOVERY;
D O I
10.1016/j.ejmech.2022.114402
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this work, a series of novel 1H-indole-2-carboxylic acid derivatives targeting 14-3-3 eta protein were designed and synthesized for treatment of liver cancer. After structural optimization for several rounds, C11 displayed a relatively better affinity with 14-3-3 eta, as well as the best inhibitory activities against several typical human liver cancer cell lines, including Bel-7402, SMMC-7721, SNU-387, Hep G2 and Hep 3B cells. Compound C11 also displayed best inhibitory activity against chemotherapy-resistant Bel-7402/5-Fu cells. Besides, C11 was rather safe against hERG and possessed moderate T1/2 and CL values in liver microsomes. In anti-proliferation, transwell and cell apoptosis assays, C11 also showed its huge potential as a potent antitumor agent. Then, Western blot assay was conducted, following analyzed by molecular docking, the anti-proliferative mechanisms of this small-molecule inhibitor were revealed. Moreover, C11 was demonstrated to induce G1-S phase cell cycle arrest in liver cancer cells.
引用
收藏
页数:15
相关论文
共 37 条
[1]   Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma [J].
Abou-Alfa, G. K. ;
Meyer, T. ;
Cheng, A. -L. ;
El-Khoueiry, A. B. ;
Rimassa, L. ;
Ryoo, B. -Y. ;
Cicin, I. ;
Merle, P. ;
Chen, Y. H. ;
Park, J. -W. ;
Blanc, J. -F. ;
Bolondi, L. ;
Klumpen, H. -J. ;
Chan, S. L. ;
Zagonel, V. ;
Pressiani, T. ;
Ryu, M. -H. ;
Venook, A. P. ;
Hessel, C. ;
Borgman-Hagey, A. E. ;
Schwab, G. ;
Kelley, R. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :54-63
[2]   Rational design, synthesis, and structure-activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors [J].
Basu, Sujay ;
Prathipati, Philip ;
Thorat, Sachin ;
Ansari, Shariq ;
Patel, Meena ;
Jain, Vaibhav ;
Jinugu, Ramana R. ;
Niranjan, Sanjay ;
De, Siddhartha ;
Reddy, Satyanarayana .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (01) :67-74
[3]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[4]   Novel Orally Active Antimalarial Thiazoles [J].
Cabrera, Diego Gonzalez ;
Douelle, Frederic ;
Feng, Tzu-Shean ;
Nchinda, Aloysius T. ;
Younis, Yassir ;
White, Karen L. ;
Wu, Quoc ;
Ryan, Eileen ;
Burrows, Jeremy N. ;
Waterson, David ;
Witty, Michael J. ;
Wittlin, Sergio ;
Charman, Susan A. ;
Chibale, Kelly .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) :7713-7719
[5]   Discovery of Small Molecule Inhibitors of Protein-Protein Interactions Using Combined Ligand and Target Score Normalization [J].
Casey, Fergal P. ;
Pihan, Emilie ;
Shields, Denis C. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (12) :2708-2717
[6]   pVHL suppresses Akt/β-catenin-mediated cell proliferation by inhibiting 14-3-3ζ expression [J].
Castaneda, Azucena ;
Serrano, Carolina ;
Antonio Hernandez-Trejo, Jose ;
Zenidel Gutierrez-Martinez, Itzel ;
Montejo-Lopez, Wilber ;
Gomez-Suarez, Mauricio ;
Hernandez-Ruiz, Marcela ;
Betanzos, Abigail ;
Candelario-Martinez, Aurora ;
Romo-Parra, Hector ;
Antonio Arias-Montano, Jose ;
Schnoor, Michael ;
Meraz Rios, Marco Antonio ;
Eugenia Gutierrez-Castillo, Maria ;
Alicia Martinez-Davila, Irma ;
Villegas-Sepulveda, Nicolas ;
Martinez-Fong, Daniel ;
Nava, Porfirio .
BIOCHEMICAL JOURNAL, 2017, 474 :2679-2689
[7]   Caspases - An update [J].
Chowdhury, Indrajit ;
Tharakan, Binu ;
Bhat, Ganapathy K. .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2008, 151 (01) :10-27
[8]   Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: The 14-3-3σ case [J].
Corradi, Valentina ;
Mancini, Manuela ;
Santucci, Maria Alessandra ;
Carlomagno, Teresa ;
Sanfelice, Domenico ;
Mori, Mattia ;
Vignaroli, Giulia ;
Falchi, Federico ;
Manetti, Fabrizio ;
Radi, Marco ;
Botta, Maurizio .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) :6867-6871
[9]   Current discovery strategies for hepatocellular carcinoma therapeutics [J].
Dai, Qiuzi ;
Zhang, Cunlong ;
Yuan, Zigao ;
Sun, Qinsheng ;
Jiang, Yuyang .
EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (02) :243-258
[10]   Copper-Mediated Tandem Oxidative C(sp2)-H/C(sp)-H Alkynylation and Annulation of Arenes with Terminal Alkynes [J].
Dong, Jiaxing ;
Wang, Fei ;
You, Jingsong .
ORGANIC LETTERS, 2014, 16 (11) :2884-2887